"A 378-bed regional referral and trauma center featuring the latest medical technology and clinical expertise."

During the past decade, Rogue Valley Medical Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 17 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 13 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rogue Valley Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rogue Valley Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Rogue Valley Medical Center" are "Breast Adenocarcinoma" (4 trials), "Breast Cancer" (4 trials), "Prostate Cancer" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Rogue Valley Medical Center" in a lesser frequency.

Most popular intervention types in "Rogue Valley Medical Center" are "Drug" (31 trials), "Other" (25 trials), "Biological" (15 trials), "Procedure" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (10 trials), "Paclitaxel" (8 trials), "Questionnaire Administration" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Rogue Valley Medical Center" are 32 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Rogue Valley Medical Center". undefined are not yet recruiting, 13 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Rogue Valley Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rogue Valley Medical Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".